A CONTINUOUS MODEL OF ANGIOGENESIS: INITIATION, EXTENSION, AND MATURATION OF NEW BLOOD VESSELS MODULATED BY VASCULAR ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETINS, PLATELET-DERIVED GROWTH FACTOR-B, AND PERICYTES

被引:36
|
作者
Zheng, Xiaoming [1 ]
Koh, Gou Young [2 ]
Jackson, Trachette [3 ]
机构
[1] Cent Michigan Univ, Dept Math, Mt Pleasant, MI 48859 USA
[2] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea
[3] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA
来源
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B | 2013年 / 18卷 / 04期
基金
新加坡国家研究基金会;
关键词
Angiogenesis; endothelial cells; pericytes; initiation; migration; maturation; vascular endothelial growth factor; Angiopoietin-1; Angiopoietin-2; Tie2; platelet-derived growth factor-B; viscoelastic model; corneal angiogenesis; antiangiogenic therapy; UP-REGULATES ANGIOPOIETIN-2; CAPILLARY NETWORK FORMATION; TUMOR-INDUCED ANGIOGENESIS; REINFORCED RANDOM-WALK; MATHEMATICAL-MODEL; SIGNAL-TRANSDUCTION; CELL SURVIVAL; NUMERICAL SIMULATIONS; VEGF RECEPTORS; TIE2; RECEPTOR;
D O I
10.3934/dcdsb.2013.18.1109
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
This work presents a continuous model for three early stage events in angiogenesis: initiation, sprout extension, and vessel maturation. We carefully examine the regulating mechanisms of vascular endothelial growth factor (VEGF) and angiopoietins (Ang1 and Ang2) on the proliferation, migration and maturation of endothelial cells through their endothelium-specific receptor tyrosine kinase VEGFR2 and Tie2, respectively. We also consider the effect of platelet-derived growth factor-B (PDGF-B) on the proliferation and migration of pericytes. For growth factors, we present a mathematical model integrating molecular reactions on blood vessels with tissue-level diffusion. For capillary extension, we develop a visco-elastic model to couple tip cell protrusion, endothelium elasticity, and stalk cell proliferation. Our model reproduces corneal angiogenesis experiments and several anti-angiogenesis therapy results. This model also demonstrates that (1) the competition between Ang1 and Ang2 is the angiogenic switch; (2) the maturation process modulated by pericytes and angiopoietins is crucial to vessel normalization and can explain the resistance to anti-VEGF therapy; (3) combined anti-pericyte and anti-VEGF therapy enhances blood vessel regression over anti-VEGF therapy alone.
引用
收藏
页码:1109 / 1154
页数:46
相关论文
共 50 条
  • [1] Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression
    Wang, Wenling
    Qi, Lifeng
    Tan, Minhan
    Zhang, Zhenting
    Du, Ju
    Wei, Xiaona
    Yao, Xin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (04) : 168.e17 - 168.e27
  • [2] Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer
    Seki, N
    Kodama, J
    Hongo, A
    Miyagi, Y
    Yoshinouchi, M
    Kudo, T
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (01) : 68 - 73
  • [3] Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B
    Yamagishi, S
    Nakamura, K
    Takenaka, K
    Matsui, T
    Jinnouchi, Y
    Imaizumi, T
    MICROVASCULAR RESEARCH, 2005, 69 (03) : 128 - 134
  • [4] Increased Vascular Delivery and Efficacy of Chemotherapy after Inhibition of Platelet-Derived Growth Factor-B
    Falcon, Beverly L.
    Pietras, Kristian
    Chou, Jeyling
    Chen, Debbie
    Sennino, Barbara
    Hanahan, Douglas
    McDonald, Donald M.
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (06): : 2920 - 2930
  • [5] Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells
    Reinmuth, Niels
    Rensinghoff, Sonja
    Raedel, Miriam
    Fehrmann, Nicole
    Schwoeppe, Christian
    Kessler, Torsten
    Bisping, Guido
    Hilberg, Frank
    Roth, Gerald J.
    Berdel, Wolfgang
    Thomas, Michael
    Mesters, Rolf M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (03) : 621 - 626
  • [6] Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
    K J O'Byrne
    M I Koukourakis
    A Giatromanolaki
    G Cox
    H Turley
    W P Steward
    K Gatter
    A L Harris
    British Journal of Cancer, 2000, 82 : 1427 - 1432
  • [7] Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer
    O'Byrne, KJ
    Koukourakis, MI
    Giatromanolaki, A
    Cox, G
    Turley, H
    Steward, WP
    Gatter, K
    Harris, AL
    BRITISH JOURNAL OF CANCER, 2000, 82 (08) : 1427 - 1432
  • [8] Vascular endothelial growth factor-B promotes in vivo angiogenesis
    Silvestre, JS
    Tamarat, R
    Ebrahimian, TG
    Le-Roux, A
    Clergue, M
    Emmanuel, F
    Duriez, M
    Schwartz, B
    Branellec, D
    Lévy, BI
    CIRCULATION RESEARCH, 2003, 93 (02) : 114 - 123
  • [9] The Role of Platelet-Derived Growth Factor-B/Platelet-Derived Growth Factor Receptor-β Signaling in Chronic Atrial Fibrillation
    Jiang, Zhiyuan
    Zhong, Guoqiang
    Wen, Lina
    Hong, Yujie
    Fang, Shu
    Sun, Peizhen
    Li, Shuo
    Li, Shanshan
    Feng, Guirong
    CARDIOLOGY, 2016, 133 (04) : 242 - 256
  • [10] Platelet-Derived Growth Factor-B Normalizes Micromorphology and Vessel Function in Vascular Endothelial Growth Factor-A-Induced Squamous Cell Carcinomas
    Lederle, Wiltrud
    Linde, Nina
    Heusel, Julia
    Bzyl, Jessica
    Woenne, Eva C.
    Zwick, Stefan
    Skobe, Mihaela
    Kiessling, Fabian
    Fusenig, Norbert E.
    Mueller, Margareta M.
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (02): : 981 - 994